JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30

Benzinga Newsdesk www.benzinga.com Neutral 52.8%

Neg 0% Neu 52.8% Pos 0%

JP Morgan analyst Lisa Gill maintains Progyny (NASDAQ:PGNY) with a Neutral and raises the price target from $27 to $30.

Comments

No comments yet. Be the first!